YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Roche Calls Illumina Offer 'Full and Fair'

February 6, 2012 | Roche's $44.50/share offering for Illumina is "a full and fair price," Roche CEO Severin Schwan told CNBC. He said the pharma company is "committed to making [the] transaction happen." CNBC
View Next Related Story
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.